PLUR Competitors & Alternatives

Compare Pluri Inc. with similar stocks in the same industry

Biotechnology

PLUR

Main Stock
$0.98
-5.88%
Tradestie Score
28
Revenue Growth
-15.8%
Analyst Upside
+1126.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other Cell Therapy
Competitive Moat: None
Core Technology Stack: Placenta-derived stromal cells, 3D bioreactor expansion
Major Customers 3
Pharmaceutical partners Research institutions Hospitals
Critical Suppliers 2
Bioreactor equipment providers Raw material suppliers
Direct Ecosystem Rivals 3

Top Competitors

218 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.07
-0.70%
$137.59M - 37 Compare
CLYM Climb Bio, Inc. Common Stock
$9.63
-3.12%
$133.50M - 45 Compare
SRZN Surrozen, Inc. Common
$30.16
-6.68%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.11
-7.41%
$110.20M - 34 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.03
+0.17%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.20
-3.74%
$67.94M - 52 Compare
PYPD PolyPid Ltd. Ordinary Shares
$6.44
+4.63%
$53.57M - 31 Compare
SABS SAB Biotherapeutics, Inc. Common Stock
$2.92
-2.67%
$20.61M - 31 Compare
SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares
$0.38
-5.77%
$4.38M 0.1 46 Compare
SVRE SaverOne 2014 Ltd. American Depositary Shares
$0.39
-9.15%
$1.85M - 37 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC None)

218 stocks in this industry